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ABSTRACT
Aim: This research is dedicated to development of a methodology for the determination of gliclazide in 
biological samples for analytical diagnostics of lethal overdose caused by the drug.
Materials and Methods: TLC method: chromatographic plates Merck silica gel 60 F254 10×10 cm in size, 
mobile phase - ethyl acetate, visualization reagent 1% vanillin solution or 5% solution of chloral hydrate. 
HPLC method: liquid chromatograph «Milichrom-A-02» with UV detecting (RF); Prontosil-120-5-C18-
AQ reverse-phase column Ø2×75 mm in diameter, 5 μm grains (Bischoff Analysetechnik und Geräte 
GmbH, Germany); Gradient elution with a mixture of two eluents (eluent A – [0.2 M solution LiClO4 – 
0.005 M solution of HClO4] and eluent B - acetonitrile); Wavelength 230 nm.
Results: Methodology for the determination of gliclazide in biological samples is developed. It includes 
an effective method of gliclazide isolation from the objects of the study, specific and selective chroma-
tographic detection methods and quantitative determination of toxicity in the extracts that had been re-
ceived. It was established that while using TLC method gliclazide was assigned an Rf value of 0,48±0,01; 
detection limit is 3.0 μg. When applying HPLC method gliclazide holding time was 7.80 min (RSD = 
0.13%), detection limit was 0.050 μg / ml, limit of the quantitative determination was 0.157 μg/ml, lin-
earity of the procedure was in the range of 0.1-20.0 μg/ml. Under the developed conditions, gliclazide 
was determined at 17.48 ± 1.32 μg/ml (RSD = 6.06%).
Conclusions: Results of the study indicate that methodology for the determination of gliclazide in bio-
logical samples that was developed can be used for analytical diagnostics of lethal overdose caused by 
the drug.
Key words: gliclazide, analytical methods of research, chemical-toxicological analysis.
RESUMEN
Objetivo: Desarrollar un método de detección de gliclazida en muestras biológicas para el diagnóstico 
analítico de los fallecimientos por sobredosis del fármaco.
Materiales y métodos: Método de CCF: placas para cromatografía Merck silica gel 60 F254 de 10×10 cm 
de tamaño, fase móvil - acetato de etilo, revelador - solución al 1% de vainillina o solución al 5% de hi-
drato de cloral. Método de HPLC: cromatógrafo líquido «Milihrom-A-02» con detección de UV (Rusia); 
columna de fase inversa Prontosil-120-5-C18-AQ de Ø2 x 75 mm, con graneado de 5 mm («Bischoff 
Analysetechnik und Geräte GmbH», Alemania); elución gradiente con una mezcla de dos eluyentes (elu-
yente A - [0,2 M solución de LiClO4 - solución de HClO 0,005 M4] y eluyente B - acetonitrilo); la longitud 
de onda es de 230 nm.
Resultados y discusión: Se desarrolló una metodología de determinación de la gliclazida en muestras 









The research work performed in the 
manuscript is done on the funding 




This work was supported by the phar-
macological departmental grant.
Conflicto de interés 
Competing interest
The authors have no affiliations with 
or involvement in any organization or 
entity with any financial interest (such as 
honoraria; educational grants; participa-
tion in speakers’ bureaus; membership, 
employment, consultancies, stock 
ownership, or other equity interest; and 
expert testimony or patent-licensing 
arrangements), or non-financial interest 
(such as personal or professional 
relationships, affiliations, knowledge or 
beliefs) in the subject matter or materi-
als discussed in this manuscript.
Received: 04.02.2018 
Accepted: 13.05.2018
Methodology of Gliclazide Detection in Biological Samples
Metodología de detección Gliclazida en muestras biológicas
Serhii I. Merzlikin1, Tetyana V. Kucher1, Krystyna Yu. Netosova1,Dmytro S. Kharchenko2
1. National University of Pharmacy. Drug and Analytical Toxicology Department
2. Ukrainian Military Medical Academy
http://dx.doi.org/10.30827/ars.v59i2.7516
86 Ars Pharm. 2018; 59(2): 85-90
Serhii I. Merzlikin, Tetyana V. Kucher, Krystyna Yu. Netosova,Dmytro S. Kharchenko
cromatográficos específicos y selectivos de detección y cuantifica-
ción de la sustancia tóxica en los extractos obtenidos. Se constató 
que al aplicarse el método de CCF la gliclazida ha sido identificada 
de acuerdo con el valor Rf 0,48±0,01; el límite de detección es de 
3,0 μg. Al aplicarse el método de HPLC se constató lo siguiente: el 
tiempo de retención de la gliclazida es de 7,80 min (RSD=0,13%), 
el límite de detección es de 0,050 μg/ml, el límite de cuantificación 
es de 0,157 μg/ml, la linealidad del método está en el intervalo de 
0,1-20,0 μg/ml. En condiciones diseñadas la gliclazida se detectó a 
un nivel de 17,48±1,32μg/ml (RSD=6,06%).
Conclusiones. Los resultados obtenidos confirman que la metodo-
logía desarrollada de detección de la gliclazida en muestras bioló-
gicos es adecuada para el diagnóstico analítico de los fallecimien-
tos por sobredosis del fármaco.
Palabras clave: gliclazida, métodos analíticos de investigación, 
análisis químico-toxicológico.
INTRODUCTION
Poisoning of chemical origin is a global healthcare problem 
all over the world. Toxicological situation in Ukraine cor-
responds to a general world and European trends of prev-
alence and lethality due to acute intoxications, which are 
often associated with the use of drugs in self-treatment and 
suicidal purposes. In some circumstances, almost every 
drug can cause poisoning.
Thus, in a period from 2010 to 2015 according to FDA and 
patientsville.com site over 600 cases of gliclazide poison-
ing have being registered all over the world. Gliclazide is 
a N-(hexahydrocyclopentane[c]pyrrol-2(1H)-ylcarbamoyl)-
4-methyl-benzenesulfonamide (Figure 1) which is a com-










Fig. 1. Chemical structure of gliclazide
Among them more than 60 cases are fatal poisonings that 
are mainly caused by intentional overdose of the drug in 
doses exceeding the therapeutic ones by 10 or more times. 
The highest number of reported poisoning cases caused by 
gliclazide is observed in the US and Western Europe, which 
is primarily explained by availability of FDA database. 
However, the number of drug poisoning deaths could be 
much higher in case of its proper registration in other coun-
tries, including Ukraine. Underestimation of lethal cases is 
caused by the lack of systematic methods for chemical-toxi-
cological analysis (CTA) in institutions of forensic examina-
tion. Therefore, there is a need of research in this area and 
results of the study will contribute to the quality of forensic 
toxicology studies.
The aim of the study is to develop a methodology for gli-
clazide determination in biological samples for analytical 
diagnostic of deaths caused by drug overdose.
MATERIALS AND METHODS
Reagents that were used comply with qualification 
«HPLC»: acetonitrile (Sigma-Aldrich Laborchemikallen, 
GmbH), methanol (Merck, Darmstadt, Germany), lithium 
perchlorate trihydrate (Sigma, Aldrich, SSHA), water bidis-
tilled (Merck, Darmstadt, Germany). All other chemicals 
used were AR grade.
For simulation of acute intoxication with gliclazide, sam-
ples of «fresh» swine liver, which was purchased in the 
nearest supermarket, were used.
Statistical analysis
Using Excel program, the method of least squares was cal-
culated for the value of relative standard deviation (RSD) 
and the linear regression analysis.
Experimental part
50 g of crushed liver is placed in a 500 ml flask, 3 ml of 
methanol-methylene chloride (1:1) solution of gliclazide 
containing 20 mg of the substance is added, solution is 
mixed and kept for 24 hours at room temperature, than 50 
ml of acetonitrile acidified with 6 M solution of chloride 
acid to pH 3.0 (on a universal indicator) is added. After that 
solution is infused for 30 minutes at a periodic monitoring 
of pH and filtered through a filter paper (red ribbon) in a 
100 ml flask. The operation of infusing biological material 
is carried out three times. Resulting extracts are combined 
and transferred to a 1000 ml flask containing 300 ml of a 
2.5% solution of sodium sulfate. Contents of the flask are 
thoroughly mixed, acidified with a 6 M solution of chloride 
acid to pH 3.0, filtered through a filter paper (red ribbon) 
into a separatory flask and extracted twice by 100 ml with 
n-hexane for 10 minutes using a mechanical shaker. After 
stratification, the contents of the flask are transferred to a 
separatory funnel, then isolate an organic layer, which is 
not subsequently investigated. The resulting water-ace-
tonitrile extracts are combined, placed in a separatory flask 
and extracted three times in 100 ml with chloroform for 
10 minutes using a mechanical shaker. The contents of the 
flask are transferred to a separatory funnel, after separation 
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the organic layer is isolated, filtered through a filter paper 
containing 5.0 g of anhydrous sodium sulfate. Chloroform 
extracts obtained by this way are combined, evaporated in 
a stream of warm air to a volume of 25 ml and used for 
research.
TLC research is carried out on chromatographic plates of 
Merck silica gel 60 F254 10×10 cm in size. The mobile phase 
is ethyl acetate. Before elution, the chromatographic plate is 
pre-impregnated with methanol and activated in a drying 
oven at 110-120°C for 0.5 h.
Experimental part
The plate is divided into three parts, the 10 μl (1 μg/ml) 
standard solution of gliclazide is applied to the starting line 
as a point in zone 1. 1 ml of chloroform extract obtained 
from the liver tissues is applied to zone 2 with a 2 cm thick 
strip. 1/3 of the chloroform extract obtained from the liver 
tissues is applied to zone 3 with a strip thickness of 2 cm. 
After chromatography is performed the plate is dried and 
zones 1 and 2 are treated with a visualisation reagent spe-
cific for gliclazide: 1% solution of vanillin or 5% solution 
of chloral hydrate. The absorbent layer of 3 × 1 cm is re-
moved from the zone 3 (in the corresponding to gliclazide 
region of Rf value) of the plate which is untreated by the 
visualisation reagent and is placed into a glass vial contain-
ing 10 ml of methanol. The vial is shaken for 5 minutes and 
the contents are filtered through a filter paper (red ribbon). 
The methanol eluate which is obtained is investigated by 
HPLC.
The HPLC studies were carried out on a liquid chroma-
tograph «Milichrom-A-02» with UV detection (RF). Pron-
tosil-120-5-C18-AQ reverse-phase column Ø2×75 mm, 5 
micron granulation (Bischoff Analysetechnik und Geräte 
GmbH, Germany) was used for the separation of the sub-
stances. Gradient elution was performed by mixing two 
eluents: eluent A – (0.2 М solution LiClO4 – 0.005 M so-
lution of HClO4) and eluent B - acetonitrile for «HPLC». 
Speed of mobile phase is 100 μl/min. Temperature ther-
mostat column – 35°C. UV spectrophotometric detection 
was performed simultaneously at 8 wavelengths: 210, 220, 
230, 240, 250, 260, 280 and 300 nm. Analysis and process-
ing of chromatograms were carried out using the program 
«Analytics-Chrom». The accuracy of the technique was pe-
riodically monitored by chromatography of a special con-
trol multicomponent solution consisting of bromide ion, 
uridine, caffeine, transerin, m-nitroaniline, p-nitroaniline 
and triftazine.
Experimental part
Eluent A was prepared using solution 1 and solution 2.
Preparation of solution 1 (4.1 М aqueous solution of LiClO4 
× 3H2O). Approximately 330.0 g of LiClO4 × 3H2O (exact 
weighting) are placed into a 500 ml volumetric flask and 
dissolved in 450.0 ml of bidistilled water. Resulting solu-
tion is mixed at 50°C until it is completely dissolved, cooled 
to room temperature, the solvent is brought to the mark 
with the same volume and filtered through a 0.45 μm pore 
size membrane filter.
Preparation of solution 2 (4 М aqueous solution of LiClO4 в 
0.1 M HClO4). In a volumetric flask of 250 ml, 2.20 ml of 0.1 
M HClO4 are measured and total volume is adjusted to the 
mark with solution 1.
Preparation of eluent A. In a volumetric flask of 200 ml, 
10.00 ml of solution 2 is measured and total volume is ad-
justed to the mark with bidistilled water.
Preparation of test solutions of gliclazide. Approximately 
10.0 mg (exact weighting) of gliclazide is placed into a 100 
ml volumetric flask, dissolved in 10.0 ml of methanol and 
adjusted to the mark with the same solvent (standard solu-
tion 1, concentration of substance 100.0 μg/ml). 20.0 ml of 
standard solution 1 is placed into a volumetric flask of 100 
ml and adjusted to the mark with the same solvent (test 
solution 1, concentration of substance 20.0 μg / ml). 10.0 
ml of standard solution 1 is placed into a volumetric flask 
of 100 ml and adjusted to the mark with the same solvent 
(standard solution 2, concentration of substance 10.0 μg/ml). 
20.0 and 5.0 ml of standard solution 1 are alternately placed 
into two 100 ml volumetric flasks and adjusted to the mark 
with the same solvent (test solution 1 and 2, concentration 
of substance 20.0 and 5.0 μg/ml). 20.0, 10.0 and 5.0 ml of 
standard solution 2 are alternately placed into three 100 ml 
volumetric flasks and adjusted to the mark with the same 
solvent (test solutions 3, 4 and 5 with concentration of 2.0, 1.0 
and 0.5 μg/ml respectively). 10,0 and 5,0 ml of test solution 
3 are alternately placed into two 100 ml volumetric flasks 
and adjusted to the mark with the same solvent (test solu-
tion 6 and 7 with concentration of substance 0.2 and 0.1 μg/
ml respectively).
All solutions were prepared at a room temperature imme-
diately before the analysis. Prepared test solutions were 
chromatographed three times, each with the above condi-
tions. Detection of the gliclazide signal was carried out at 
a wavelength of 230 nm. Volume of the sample was 20 μl. 
Chromatographic results are used to construct the calibra-
tion graph.
RESULTS AND DISCUSSION
Results presented in this article are a continuation of a se-
ries of systematic chemical and toxicological studies of anti-
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diabetic agents (sulfonylureas derivatives) conducted with 
the aim of developing methods for analytical diagnostics of 
their lethal overdoses [4].
Research methodology corresponds to the international 
practice of CTA on a poisonous chemical substance and 
includes development of an effective method for isolating 
gliclazide from a biological material. On top of this sensi-
tive, specifi c and selective methods for detection and quan-
titative determination of toxicity in resulting extracts are 
developed.
Simulation of acute intoxication with gliclazide was carried 
out in accordance with the generally accepted practice of 
experimental toxicology, namely by saturation of a sample 
of «fresh» swine liver with lethal doses of the drug. Cal-
culation of the administered doses of the toxicant was car-
ried out considering the results of the analysis of its suicidal 
overdoses, toxicokinetics and results from the simulation of 
acute intoxication in rats [5-7]. Dose of inserted gliclazide 
was 20 mg recalculated on 50 g of biological object.
An acetonitrile method was used to isolate the gliclazide 
from a biological samples which is applicable at directed 
CTA on certain medicinal substances including sulfonylu-
reas derivatives [8]. Chloroform extract obtained by this 
method was tested by TLC.
Chromatographic zones 1 and 2 of the thin layer were 
used to identify the gliclazide, zone 3 - to purify 1/3 of the 
chloroform extract from the coextractive substances. It was 
found that after chromatographic zones 1 and 2 were treat-
ed with a specifi c reagent with 1% vanillin solution or 5% 
chloral hydrate solution on a chromatogram stained spots 
(blue and brown, respectively) with gliclazide-correlated 
values with Rf values of 0.48 ± 0.01 were identifi ed. Limit 
for detection of a toxicant is 3.0 μg.
Methanol eluate obtained from the untreated visualisation 
reagent of the thin layer chromatographic zone 3 was in-
vestigated by HPLC to confi rm results for identifi cation of 
gliclazide and for quantifying the toxicant in a chloroform 
extract.
Presence of gliclazide in the sample was determined by the 
parameters of the retention time the toxicant and spectral 
characteristics.
It has been established that gliclazide retention time in 
the studied eluate coincides with the retention time of the 
standard gliclazide sample (Figure 2) and is 7.80 min (RSD 
= 0.13%).
Fig. 2. Chromatogram of the standard gliclazide sample
Quantitative content of gliclazide was determined by cali-
brating peak area of the methanolic solution of the stand-
ard gliclazide sample from the concentration (μg / ml) de-














Fig. 3. Graph of gradient dependence of peak area of metha-
nolic solution of standard sample gliclazide on concentra-
tion
Regression coeffi cients of the calibration graph were calcu-
lated by the method of least squares:
S = 0.0089 × C + 0.0001, where
S – peak area, st. un.;
С – concentration of substance, μg / ml.
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It is established that free part of the equation of the calibra-
tion graph in determining the significance does not differ 
significantly from zero. This causes the transition of the 
equation to the following form: у = b×x. Therefore, the fol-
lowing equation was used to determine the concentration 
of gliclazide in the study objects:
S = 0.0089×C
Solubility of the calibrated graph in the coordinates (S, st. 
un) - (C, μg/ml) is in the range of 0.1-20.0 μg / ml. Valida-
tion characteristics of the method are determined (Table 1).
Table 1. Validation characteristics of the method of quantitative determination of gliclazide
Parameter Value
Free part of regression equation (а) 9.67×10-5







Detection limit, μg/ml 0.050
Limit of quantitative determination, μg/ml 0.157
Results of the quantitative determination of gliclazide in 
samples of methanol eluate obtained from thin layers are 
given in Table 2.
Table 2. Results by quantitative determination of gliclazide (n=5, P=0.95)
X , μg/ml S XS �� e RSD, %
17.48 1.06 4.74×10-1 1.32 7.53 6.06
Results of the quantitative determination of gliclazide in 
biological samples obtained in this study and calculated 
percentage of relative standard deviation indicate that this 
technique is suitable for solving the problem described as 
an aim of the study.
CONCLUSIONS
Having in mind all the described above, proposed acetoni-
trile method is determined to be effective for the isolation 
of gliclazide from biological material at directed CTA to the 
toxicant. Results of the detection and quantitative determi-
nation of gliclazide in the extracts are reproducible and in-
dicate sufficient accuracy, specificity and selectivity of the 
analytical methods used. In general, we can conclude that 
methodology developed for determining gliclazide in bio-
logical samples is suitable for analytical diagnosis of lethal 
overdose drug.
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